Increase in co-payment for medicines: what does this mean for the insurance plans of employers and their employees?
Starting in 2026, the federal government will introduce a minimum co-payment of €2 for all medicines you buy at the pharmacy. The General Council of the RIZIV describes the purpose of this measure as follows: ‘This is a solidarity contribution that will be used to reinvest in better social security protection for patients.’ But what does this mean in practice for the medical plans you provide, as an employer for your employees?